New hope for kids in shock: drug trial targets stubborn low blood pressure
NCT ID NCT07212686
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study tests a drug called Angiotensin II (Giapreza) in 30 children under 18 with life-threatening low blood pressure (vasodilatory shock) that hasn't improved with fluids or standard medicines. The goal is to see if the drug can safely raise blood pressure and reduce the need for other strong blood pressure medications. Participants receive the drug alongside usual care and are monitored for side effects and kidney blood flow.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASODILATORY SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cohen Children's Medical Center
Queens, New York, 11101, United States
-
Cohen Children's Medical Center of Northwell Health
New Hyde Park, New York, 11040, United States
Conditions
Explore the condition pages connected to this study.